| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.1 | — |
| Net income | -3.4 | -2.0 |
| EPS (diluted, $ a share) | $-0.20 | $-0.19 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
Source
Read the filing ↗
10-Q filed with the SEC, NASDAQ: COCP. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Cocrystal Pharma, Inc.: key numbers
- Share price
- $0.9777Close, Nov 16
- Market cap
- $18.8M
- Shares outstanding
- 19.26MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.